NLRP6 and colorectal carcinoma: Finally, finding new ways to harness the innate immunity of tumors is currently of particular interest [32] and re-establishing normal expression of NLRP6 in tumor cells may confer therapeutic benefits by blocking progression towards advanced CRC.